Breakthrough model for human cancer may improve development of cancer drugs
Monday, April 6, 2009 - 17:14
in Health & Medicine
AVEO Pharmaceuticals, Inc., a biopharmaceutical company leveraging breakthrough discoveries in cancer biology to discover, develop and commercialize targeted oncology therapies, today announced findings from its novel human-in-mouse (HIM) cancer model system, in which AVEO successfully created invasive human tumors from primary human breast tissue that develop over time in mice and mimic human tumor behaviors and response. The findings were published this week in the Early Edition of the Proceedings of the National Academy of Sciences.
Read the whole article on Physorg
More from Physorg
Related
- New investigational treatment for bladder cancer, identified with Columbia-developed research modelThu, 12 Mar 2009, 16:58:05 EDT
- Scientists create mouse model of melanoma that generates hope for the use of targeted therapiesThu, 12 Mar 2009, 16:58:08 EDT
- Discovery leads to rapid mouse 'personalized trials' in breast cancerFri, 4 Sep 2009, 15:30:56 EDT
- Breast cancer drug shows promise for treating, preventing progestin-dependent tumorsWed, 28 Jan 2009, 14:37:05 EST
- Social isolation worsens cancerTue, 29 Sep 2009, 13:30:47 EDT